Particle.news

Download on the App Store

Novo Nordisk Expands $499 Wegovy and Ozempic Pricing to Costco and Sam’s Club

The broader rollout targets self-pay buyers to channel demand toward FDA-approved products.

Overview

  • Sam’s Club pharmacies now sell Wegovy and Ozempic for $499 per month, matching Costco and the drugmaker’s direct and partner offers such as GoodRx.
  • Purchases still require a valid prescription, and access at warehouse pharmacies is limited to members, with Sam’s Club offering home delivery and varying fees by membership tier.
  • Novo Nordisk’s U.S. president said the retail strategy aims to provide patients with the real, authenticated medications.
  • Many insurers do not fully cover GLP-1 drugs, and a 2024 KFF survey found 54% of users reported difficulty affording them.
  • Wegovy is FDA-approved for chronic weight management and Ozempic is approved for type 2 diabetes, as the FDA continues to warn against compounded copycat versions.